Neo-Science

𝗣𝗿𝗼𝗳. Ken Herrmann, a Nuclear Medicine Specialist, highlights the essential role of theranostic centers in delivering personalized cancer care at the 𝗘𝗔𝗡𝗠 𝗨𝗔𝗘 𝗖𝗵𝗮𝗽𝘁𝗲𝗿 𝟮𝟬𝟮𝟰. This conference united global and local experts to advance nuclear medicine and theranostics through innovative presentations and impactful discussions. Endorsed by Emirates Oncology Society Scientific Partners: European Association of Nuclear Medicine (EANM) and 𝗥𝗟𝗧 𝗔𝗰𝗮𝗱𝗲𝗺𝘆 Sponsored by Novartis Gulf | نوفارتس الخليج Managed by: Conveners ✅📚 𝗧𝗵𝗶𝘀 𝗰𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲 𝘄𝗮𝘀 𝗖𝗠𝗘 𝗮𝗰𝗰𝗿𝗲𝗱𝗶𝘁𝗲𝗱 𝘄𝗶𝘁𝗵 𝟱.𝟳𝟱 𝗖𝗠𝗘 𝗰𝗿𝗲𝗱𝗶𝘁𝘀 𝗳𝗿𝗼𝗺 𝘁𝗵𝗲 𝗗𝘂𝗯𝗮𝗶 𝗛𝗲𝗮𝗹𝘁𝗵 𝗔𝘂𝘁𝗵𝗼𝗿𝗶𝘁𝘆. #EOS2024 #EANMUAE #Theranostics #NuclearMedicine #CancerCare #HealthcareInnovation #CMEAccredited #NovartisGulf #Conveners

🌟 An incredible week at the 16th Medical Genetics Congress in Antalya! 🌟   MGI, together with our trusted partner Invitrotek, proudly participated in Turkey’s largest genomic event in Antalya, #the16thMedicalGeneticsCongress. We are thrilled to introduce our latest innovations - the CycloneSEQ-WT02 and DNBSEQ-E25 sequencer, and the energy at the congress was truly inspiring. The excitement and curiosity around our technologies were beyond our expectations! Thank you to everyone who stopped by our booth, shared ideas, and explored how we can push the boundaries of genomics together. Your passion motivates us to keep innovating and delivering solutions that empower the genomic community. A heartfelt thanks to the organizers for hosting such a fantastic event and to all attendees for your enthusiasm and support. We can’t wait to continue this journey with you and see how we can shape the future of omics together. 📸 Check out some highlights from the event below!   #MedicalGenetics #CycloneSEQ #E25 #Turkey #Innovation #MGI #FutureOfOmics #DNBSEQ

We are delighted to welcome Jean-Baptiste Mariaux to OncoDNA as the new 𝗕𝘂𝘀𝗶𝗻𝗲𝘀𝘀 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 𝗠𝗮𝗻𝗮𝗴𝗲𝗿 𝗳𝗼𝗿 𝘁𝗵𝗲 𝗗𝗔𝗖𝗛 𝗿𝗲𝗴𝗶𝗼𝗻. With over 20 years of experience in genomics, working with companies such as IDT, Qiagen, and Thermo Fisher, Jean-Baptiste has established strong partnerships in the DACH region, Benelux, and France. He aims to support our growth in this region. Welcome aboard, Jean-Baptiste - we look forward to achieving great things together! 👏 #WelcomeToTheTeam #OncoDNA #PrecisionMedicine

🌟Discover the latest trends in spatial biology by reading the #GEN ebook <Spatiotemporal Omics: Advances to Integrate Multi-Omics Data>! This eBook will discuss some of the wide-ranging applications of spatial technology using examples that demonstrate the technology’s ability to provide a more fine-grained picture of cells’ underlying molecular mechanisms in areas such as digital pathology and developmental biology. Key takeaways include: - The capabilities of Stereo-seq technology, designed for exploring the whole transcriptome at subcellular resolution from fresh frozen and FFPE samples up to decimeter-scale. - Stereo-seq’s ability to integrate multi-omics data such as protein expression information for cell-type identification, tissue microenvironment exploration, and more. 📕 Download the Ebook on Genetic Engineering & Biotechnology News page: https://lnkd.in/gUyv8hkw STOmics #SpatialBiology #MultiOmics #DevelopmentalBiology #ResearchInnovation

Maximize efficiency in laboratory data analysis: We are delighted to announce that we have formed a partnership with VETTE EDV-Beratung & Entwicklung GmbH. This collaboration creates a powerful interface between VETTE-EDV software TransGraph and MACHEREY-NAGEL photometers NANOCOLOR® VIS II and UV/VIS II, enabling a fully automated solution for data acquisition and analysis directly from the laboratory instrument into the TransGraph LIMS module. This results in considerable time savings that can be allocated to data-based decision-making. The direct interface enables the automatic transfer of measurement results and their evaluation in real time, reducing the need for manual work steps, minimizing potential sources of error, and ensuring the integrity of the laboratory samples' data. For more information, please see our collaboration flyer: https://lnkd.in/dNwxZ4kj You can also visit our collaboration landing page: https://lnkd.in/efMt6F4T  #cooperation #innovation #water

Technology transfer is more than just the exchange of innovations—it’s about delivering advanced health solutions that empower communities and transform healthcare systems. We’re truly honored to have our efforts recognized by our valued partners: ✨ Zentya in Slovakia and NIMGenetics in Spain share their experiences on how BGI Genomics’ initiatives are advancing genetic testing and improving patient outcomes. 🗨️ “BGI Genomics has supported us primarily in two pillars that we consider the most important when you are a partner with someone: training and technical service," said our partner NIMGenetics in the interview video. With over 100 technology transfer projects completed in 36 countries, we’ve collaborated with partners across #Uruguay, #Thailand, #Kazakhstan, #UAE, #Rwanda, #Vietnam, #India, #Spain, #Mexico, #Indonesia, #Malaysia, and beyond. Together, we’ve successfully implemented solutions like NIPT, cWES, carrier screening, CRC detection, and hereditary cancer testing—delivering affordable reproductive health and cancer screening services to millions globally. Discover how we’re shaping the future of #PrecisionMedicine and making a lasting impact. 💙 #HealthcareInnovation #TechnologyTransfer #BGIInsight #BGIGeneTest

B-cell acute lymphoblastic leukemia (B-ALL) remains the most prevalent hematologic malignancy in children and a leading cause of mortality, with management complicated by its heterogeneity and relapse risk. In a recent Geneseeq-collaborated study, the researchers investigated the molecular landscape of B-ALL. Minimal residual disease (#MRD) testing was performed using the Geneseeq Hemasalus™ panel. The results highlighted the potential of ctDNA and bone marrow profiling to provide critical prognostic insights for pediatric B-ALL management. Read more about this study: https://lnkd.in/gZeqqtff Learn more about Hemasalus™: https://lnkd.in/g3RuzJVk #pediatriconcology #ctDNA #nextgenerationsequencing #precisionmedicine #cancerresearch #hematology #leukemia

How can multi-omic technologies decode the molecular drivers of cancer’s initiation, growth, and progression? Cancer is a disease of complexity, shaped by the interplay of genetic mutations, epigenetic changes, and proteomic dysregulation. Integrating these diverse molecular layers through multi-omics offers an unprecedented view into the mechanisms that fuel tumor evolution and resistance, opening doors to targeted diagnostics and therapies. 📅 PMWC 2025 Session Spotlight: Multi-omic Characterization of Cancer Development and Progression (Track 4, Day 3) 📍 When and Where: February 7, 2025, Santa Clara Convention Center Session Chair: Dr. Kathleen C. Barnes (Oxford Nanopore Technologies) – A visionary leader leveraging real-time sequencing to accelerate the integration of multi-omic data into precision oncology. Featured Panelists: Dr. Carol Greider (University of California, Santa Cruz), Nobel Laureate, whose work on telomerase and genomic instability underpins the foundational understanding of cancer biology. Dr. Orit Rozenblatt-Rosen (Genentech), whose cutting-edge research in single-cell and spatial genomics maps the intricate dynamics of tumor ecosystems. Dr. Emily Leproust (Twist Bioscience), a pioneer in synthetic biology, developing transformative tools for cancer diagnostics and therapeutic discovery. Session Highlights: Insights into how multi-omics captures the molecular complexity of cancer. The role of advanced technologies in identifying actionable biomarkers and pathways. Strategies for overcoming barriers to translating multi-omic research into clinical oncology. This session brings together trailblazers at the forefront of multi-omic innovation to explore the next wave of breakthroughs in cancer research and precision medicine. See the full program: https://lnkd.in/gPtkWZbQ Dr Emma Stanton, Alex Doniach, Sara Agee Le, Megan León, Patrick Finn, Jimmy Jin, Ian Estrin, Sean Hanlon, Pinaki Sarder, Alexandra Lujan, Karen Ring, Ph.D. #PMWC25 #CancerResearch #MultiOmics #OncologyInnovation PMWC - Precision Medicine World Conference

While removing contaminants like 𝗛𝗴2+ from effluents has been practiced for some time, the traditional methods often result to disposal in landfills or incineration.  These approaches can cause significant environmental harm, as these they frequently involve hazardous materials containing toxic metals, carcinogenic compounds, and other dangerous substances. However, the 𝐋𝐔𝐌𝐈𝐍𝐀 3300 𝐀𝐭𝐨𝐦𝐢𝐜 𝐅𝐥𝐮𝐨𝐫𝐞𝐬𝐜𝐞𝐧𝐜𝐞 𝐒𝐩𝐞𝐜𝐭𝐫𝐨𝐦𝐞𝐭𝐞𝐫, in combination with multi-functional ion imprinted polymers (IIPs) offers an environmentally safe solution to detect and remove these toxic metals effectively, achieving ppt-level detection limits for 𝐦𝐞𝐫𝐜𝐮𝐫𝐲 and 𝐡𝐲𝐝𝐫𝐢𝐝𝐞-𝐟𝐨𝐫𝐦𝐢𝐧𝐠 𝐞𝐥𝐞𝐦𝐞𝐧𝐭𝐬 to ensure precise and reliable analysis. Read the blog below for more details!  https://lnkd.in/g4tEDFXE 𝐀𝐮𝐭𝐡𝐨𝐫𝐬: Jéssica de Vasconcelos Cardoso Barros, Joao Daniel Santos Castro, Cesario Francisco das Virgens 𝐎𝐫𝐠𝐚𝐧𝐢𝐳𝐚𝐭𝐢𝐨𝐧: -         UNEB - Universidade do Estado da Bahia -         Zhejiang University

Yikon is thrilled to announce the publication of groundbreaking joint research with Prof. Shang in Frontiers in Endocrinology. This study evaluates the utility of polygenic risk scores (PRS) in predicting early menopause (EM) and investigates associated clinical characteristics and genetic risk factors. 📊 Key Findings: ✅The PRS model showed good predictive accuracy in the Chinese cohort (AUC = 0.723). The proportion of high-risk women in the EM group was significantly higher than in the PGT-M control group (OR = 3.78) and the UK Biobank group with normal menopause age (OR = 5.11). ✅This research developed a PRS model as a valuable tool for predicting EM risk. The analysis also showed that high-risk women tended to be taller, suggesting that genetic factors related to EM may influence growth and development. ✅Identified risk factors for EM include familial contentment, COVID-19 vaccination, staying up late, and exposure to smoking and alcohol in husbands. 🔗 Full-text article: https://lnkd.in/gcumuVgq #PGT #PGTM #ReproductiveGenetics #GeneticTesting #ReproductiveMedicine #ReproductiveHealth #FertilityResearch #MedicalInnovation #NextGenerationSequencing #PrecisionMedicine